Results for Chemicals & Small Molecules ( 97555 )
- Ref: TP1937L1Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mgFrom: DKK1,133.00
RFRP-1 (human) acetate(311309-25-8 free base) (Legacy Tebubio ref. 282TP1937L1). RFRP-1 (human) acetate is a potent endogenous NPFF receptor agonist (EC50 values are 0.0011 and 29 nM for NPFF2 and NPFF1, respectively). Attenuates contractile function of isolated rat and rabbit cardiac myocytes. Reduces heart rate, stroke volume, ejection fraction and cardiac output, and increases plasma prolactin levels in rats. GnIH homolog.
- From: DKK1,170.00
RS09 2TFA (1449566-36-2 free base) (Legacy Tebubio ref. 282TP1938L). RS09 2TFA (1449566-36-2 free base) is a TLR4 agonist. Promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro. It acts as an adjuvant in vivo and enhances X-15 specific antibody serum concentrations.
- Ref: TP1939L1Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 500 mg, 10 mgFrom: DKK1,920.00
RVD-Hpα acetate(1193362-76-3 free base) (Legacy Tebubio ref. 282TP1939L1). RVD-Hpα acetate is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. Also high affinity CB2 positive allosteric modulator (Ki = 50 nM).
Ac-RYYRIK-NH2 (Legacy Tebubio ref. 282TP1940). High affinity ligand for the NOP site (Ki = 1.5 nM). Antagonizes nociceptin-stimulated GTP binding in rat brain and the chronotropic effect of nociceptin on rat cardiomyocytes. However, displays potent agonist properties in vivo, inhibiting locomotor activity in mice.
- From: DKK2,513.00
Ac-RYYRIK-NH2 acetate (Legacy Tebubio ref. 282TP1940L1). Ac-RYYRIK-NH2 acetate is an agonist at nociceptin/orphanin FQ(noc/OFQ) receptors, affecting spontaneous locomotor activity. Ac-RYYRIK-NH2 acetate is a partial agonist on ORL1 transfected in CHO cells, antagonizes the stimulation of [35S]-GTPgammaS binding to G proteins by noc/OFQ in membranes and sections of rat brain.
pep2-AVKI (Legacy Tebubio ref. 282TP1942). pep2-AVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).